Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

Detalles Bibliográficos
Autores principales: Girardin, François R., Cohen, Karen, Schwenkglenks, Matthias, Durand-Zaleski, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229043/
https://www.ncbi.nlm.nih.gov/pubmed/37261286
http://dx.doi.org/10.3389/fphar.2023.1210002
_version_ 1785051151366881280
author Girardin, François R.
Cohen, Karen
Schwenkglenks, Matthias
Durand-Zaleski, Isabelle
author_facet Girardin, François R.
Cohen, Karen
Schwenkglenks, Matthias
Durand-Zaleski, Isabelle
author_sort Girardin, François R.
collection PubMed
description
format Online
Article
Text
id pubmed-10229043
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102290432023-05-31 Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment Girardin, François R. Cohen, Karen Schwenkglenks, Matthias Durand-Zaleski, Isabelle Front Pharmacol Pharmacology Frontiers Media S.A. 2023-05-16 /pmc/articles/PMC10229043/ /pubmed/37261286 http://dx.doi.org/10.3389/fphar.2023.1210002 Text en Copyright © 2023 Girardin, Cohen, Schwenkglenks and Durand-Zaleski. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Girardin, François R.
Cohen, Karen
Schwenkglenks, Matthias
Durand-Zaleski, Isabelle
Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
title Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
title_full Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
title_fullStr Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
title_full_unstemmed Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
title_short Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
title_sort editorial: pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229043/
https://www.ncbi.nlm.nih.gov/pubmed/37261286
http://dx.doi.org/10.3389/fphar.2023.1210002
work_keys_str_mv AT girardinfrancoisr editorialpharmacoeconomicsintheeraofhealthtechnologyassessmentandoutcomesresearchtoprioritizeresourceuseinnovationandinvestment
AT cohenkaren editorialpharmacoeconomicsintheeraofhealthtechnologyassessmentandoutcomesresearchtoprioritizeresourceuseinnovationandinvestment
AT schwenkglenksmatthias editorialpharmacoeconomicsintheeraofhealthtechnologyassessmentandoutcomesresearchtoprioritizeresourceuseinnovationandinvestment
AT durandzaleskiisabelle editorialpharmacoeconomicsintheeraofhealthtechnologyassessmentandoutcomesresearchtoprioritizeresourceuseinnovationandinvestment

Ejemplares similares